Keyphrases
Anticoagulants
100%
Low Molecular Weight Heparin
100%
Enoxaparin
100%
Hemorrhagic Complications
100%
Hospital Practice
100%
Major Haemorrhage
85%
Controlled Experiment
28%
Impaired Renal Function
28%
Warfarin
28%
Chronic Liver Disease
28%
Proton Pump Inhibitors
28%
Disease Treatment
14%
Internal Medicine Wards
14%
Injection Site
14%
Twice Daily
14%
Consecutive Patients
14%
Medical Patients
14%
Older Patients
14%
Clinical Setting
14%
Pulmonary Embolism
14%
Non-associated
14%
Stable Angina
14%
Deep Vein Thrombosis
14%
Prospective Observational Study
14%
Anticoagulant Drugs
14%
Routine Clinical Practice
14%
Concomitant Treatment
14%
University Teaching Hospital
14%
Non-injectivity
14%
Nursing and Health Professions
Anticoagulant Agent
100%
Bleeding
100%
Low Molecular Weight Heparin
100%
Enoxaparin
100%
Warfarin
18%
Chronic Liver Disease
18%
Proton Pump Inhibitor
18%
Ward
9%
Clinical Practice
9%
Lung Embolism
9%
Deep Vein Thrombosis
9%
Unstable Angina Pectoris
9%
Teaching Hospital
9%
Injection Site Bleeding
9%
Pharmacology, Toxicology and Pharmaceutical Science
Bleeding
100%
Anticoagulant Agent
100%
Low Molecular Weight Heparin
100%
Enoxaparin
100%
Warfarin
18%
Proton Pump Inhibitor
18%
Chronic Liver Disease
18%
Observational Study
9%
Clinical Study
9%
Unstable Angina Pectoris
9%
Deep Vein Thrombosis
9%
Lung Embolism
9%
Controlled Clinical Trial
9%
Injection Site Bleeding
9%
Medicine and Dentistry
Antithrombotic
100%
Bleeding
100%
Low Molecular Weight Heparin
100%
Kidney Function
18%
Warfarin
18%
Chronic Liver Disease
18%
Proton-Pump Inhibitor
18%
Internal Medicine
9%
Clinical Study
9%
Pulmonary Embolism
9%
Observational Study
9%
Unstable Angina Pectoris
9%
Deep Vein Thrombosis
9%
Controlled Clinical Trial
9%
Injection Site Bleeding
9%